which glp 1 drugs are approved for obesity Market Overview: GLP-1 Agonists and the Market | Blog GLP-1 Drugs for Weight Loss:

Absolute Contraindications Do not use GLP-1 and dual GIP/GLP-1 medications if you have any of the following: A personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) A history of pancreatitis or symptomatic gastroparesis Severe gastrointestinal disease Pregnant or planning pregnancy Final Thoughts GLP1 and dual GIP/GLP1 receptor are now widely used to help manage type 2 diabetes and obesity

It is important to identify those who would benefit most, he adds

& Latz, E

She says that metformin can often serve as an easy add-on treatment because its relatively affordable and has been around for a long time

Participants titrating up to the highest dose of 36 milligrams lost an average of 12.4% of their initial body weight (27.3 pounds) over the course of the 72-week study

10.1007/s10552-012-9896-y 92 Klubo-GwiezdzinskaJ.CostelloJ.PatelA.BauerA.JensenK.MeteM.et al (2013)